Publisher: Medscape


When Your Loved Ones Trust TikTok Over Their Doctor — and You

In the Media Icon

Recently, Quincy Harberger, MD, found himself discussing cardiovascular disease with his uncle.


Do We Need to Rethink MS Classification?

In the Media Icon

Welcome to Medscape. I’m your host, Dr. Andrew Wilner.


Drug-Resistant Shigella Surges in Adult Men

In the Media Icon

Cases of extensively drug-resistant (XDR) Shigella, for which no approved treatment is available, increased significantly between 2011 and 2023, based on data from approximately 17,000 isolates.


The Ethics of Referring Patients to the Hospital Pharmacy

In the Media Icon

As an increasing number of physicians leave private practice to work for hospitals or private equity firms, the risk of conflicts of interest increases.


RSV Springs Ahead

In the Media Icon

“A ripple effect from the COVID pandemic may be one reason for the shift in RSV circulation this year, as natural immunity to RSV may have been reduced with mitigation measures that were in place at the time,” said Shirin Mazumder, MD, infectious diseases specialist and associate professor at the University of Tennessee Health Science… Read More


You Had a Seizure, No I Didn’t: The Accuracy of Patient Seizure Diaries

In the Media Icon

Andrew Wilner is a professor of neurology at the University of Tennessee Health Science Center, Memphis, and a seasoned neurologist and epilepsy expert who has mastered the less conventional locum career path.


Exercise Training Benefits Patients With HIV Below the Surface

In the Media Icon

A 16-week exercise training program showed broad benefits, including cellular damage repair and slowdown in epigenetic aging, in people with HIV (PWH), based on new data presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2026 Annual Meeting.


HIV Hits the Nervous System Early

In the Media Icon

Cerebrospinal fluid (CSF) samples from individuals with early HIV infection already showed signs of inflammation compared to samples from individuals without HIV, based on new data presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2026 Annual Meeting.